Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. |
| |
| Authors: | Kara B Anthony Neil O Fishman Darren R Linkin Leanne B Gasink Paul H Edelstein Ebbing Lautenbach |
| |
| Affiliation: | Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104, USA. kara.anthony@uphs.upenn.edu |
| |
| Abstract: | Eighteen patients received tigecycline as treatment for infection due to multidrug-resistant gram-negative bacilli, including Acinetobacter baumannii and Klebsiella pneumoniae carbapenemase- and extended-spectrum beta-lactamase-producing Enterobacteriaceae. Pretherapy minimum inhibitory concentration values for tigecycline predicted clinical success. Observed evolution of resistance during therapy raises concern about routine use of tigecycline in treatment of such infections when other therapies are available. |
| |
| Keywords: | |
|
|
